Cargando…

Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment

There are fewer than normal glucose transporters at the blood-brain barrier (BBB) in Alzheimer’s disease (AD). When reduced expression of transporters aggravates the symptoms of AD, the transporters become a potential target of therapy. The incretin hormone GLP-1 prevents the decline of cerebral met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gejl, Michael, Brock, Birgitte, Egefjord, Lærke, Vang, Kim, Rungby, Jørgen, Gjedde, Albert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727512/ https://www.ncbi.nlm.nih.gov/pubmed/29235507 http://dx.doi.org/10.1038/s41598-017-17718-y

Ejemplares similares

Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain
por: Gejl, Michael, et al.
Publicado: (2013)

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
por: Gejl, Michael, et al.
Publicado: (2016)

Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia
por: Gejl, Michael, et al.
Publicado: (2014)

Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial
por: Gejl, Michael, et al.
Publicado: (2017)

Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats
por: DellaValle, Brian, et al.
Publicado: (2016)

Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma
por: DellaValle, Brian, et al.
Publicado: (2016)

Blood-brain transfer of Pittsburgh compound B in humans
por: Gjedde, Albert, et al.
Publicado: (2013)

Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients
por: Stender, Johan, et al.
Publicado: (2015)

Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?
por: Egefjord, Lærke, et al.
Publicado: (2009)

Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes
por: Melchiorsen, Josefine U, et al.
Publicado: (2023)

The Effects of a GLP-1 Analog on Glucose Homeostasis in Type 2 Diabetes Mellitus Quantified by an Integrated Glucose Insulin Model
por: Røge, RM, et al.
Publicado: (2015)

Systematic medication review and health-related outcome in elderly patients acutely admitted to an orthopaedic ward: a randomised controlled study
por: Lisby, Marianne, et al.
Publicado: (2010)

Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction
por: Pan, Hongchao, et al.
Publicado: (2019)

GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy
por: Złotek, Magdalena, et al.
Publicado: (2023)

Oral GLP1 Analog: Where Does the Tide Go?
por: Gardner, Hannah, et al.
Publicado: (2020)

N‐terminal alterations turn the gut hormone GLP‐2 into an antagonist with gradual loss of GLP‐2 receptor selectivity towards more GLP‐1 receptor interaction
por: Gabe, Maria Buur Nordskov, et al.
Publicado: (2022)

Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial
por: Svart, Mads, et al.
Publicado: (2018)

Nationwide trends in glucose-lowering drug use, Denmark, 1999–2014
por: Christensen, Diana Hedevang, et al.
Publicado: (2016)

SLC30A3 Responds to Glucose- and Zinc Variations in ß-Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During ß-Cell Stress
por: Smidt, Kamille, et al.
Publicado: (2009)

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
por: Rowlands, Jordan, et al.
Publicado: (2018)

Protective Effect of a GLP-1 Analog on Ischemia-Reperfusion Induced Blood–Retinal Barrier Breakdown and Inflammation
por: Gonçalves, Andreia, et al.
Publicado: (2016)

Design and evaluation of novel thrombin-based GLP-1 analogs with peptidic albumin binding domain for the controlled release of GLP-1
por: Niu, Xianli, et al.
Publicado: (2020)

Brain GLP‐1 and the regulation of food intake: GLP‐1 action in the brain and its implications for GLP‐1 receptor agonists in obesity treatment
por: Trapp, Stefan, et al.
Publicado: (2021)

Use of GLP‐1 receptor agonists and subsequent risk of alcohol‐related events. A nationwide register‐based cohort and self‐controlled case series study
por: Wium‐Andersen, Ida Kim, et al.
Publicado: (2022)

SAT028 Beneficial Effect On Intestinal Growth Of A Long-Acting GLP-2 Analog, HM15912, After Treatment Switching From Conventional GLP-2 Drug Or Other Long-Acting GLP-2 Analogs Under Clinical Development In Animal Model
por: Park, Cho Rong, et al.
Publicado: (2023)

GLP-1 Analog Alleviated Cognitive Dysfunction in Aged Rats Anaesthetized with Sevoflurane
por: Zhang, Qin, et al.
Publicado: (2022)

Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy
por: Shi, Shaomin, et al.
Publicado: (2023)

Trajectories of Brain Lactate and Re-visited Oxygen-Glucose Index Calculations Do Not Support Elevated Non-oxidative Metabolism of Glucose Across Childhood
por: Benveniste, Helene, et al.
Publicado: (2018)

Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome
por: Maxel, Trine, et al.
Publicado: (2017)

Deep Brain Stimulation Reveals Emotional Impact Processing in Ventromedial Prefrontal Cortex
por: Gjedde, Albert, et al.
Publicado: (2009)

Novel GLP-1 Analog Supaglutide Stimulates Insulin Secretion in Mouse and Human Islet Beta-Cells and Improves Glucose Homeostasis in Diabetic Mice
por: Ren, Liwei, et al.
Publicado: (2019)

Is lactate a volume transmitter of metabolic states of the brain?
por: Bergersen, Linda H., et al.
Publicado: (2012)

Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies
por: Szczesnowicz, Aleksandra, et al.
Publicado: (2023)

Low Residual CBF Variability in Alzheimer’s Disease after Correction for CO(2) Effect
por: Rodell, Anders Bertil, et al.
Publicado: (2012)

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
por: Du, Haiyang, et al.
Publicado: (2022)

GLP-1 improves neuropathology after murine cold lesion brain trauma
por: DellaValle, Brian, et al.
Publicado: (2014)

Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose
por: Wium-Andersen, I K, et al.
Publicado: (2019)

Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes
por: Gutierrez, Absalon D., et al.
Publicado: (2022)

Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
por: Jensen, Nicole Jacqueline, et al.
Publicado: (2020)

Transferable learning on analog hardware
por: Vadlamani, Sri Krishna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sgud8uobt9va5dse16k3rs39l0